Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Dosage Regimens: Designs and Approaches01:28

Dosage Regimens: Designs and Approaches

Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Brain-gut axis imaging, motion correction with [ <sup>11</sup> C]-carfentanil total-body PET.

medRxiv : the preprint server for health sciences·2026
Same author

A multi-modal flow phantom for quantitative PET/Spectral CT.

bioRxiv : the preprint server for biology·2026
Same author

Realization of Long Axial Field-of-View PET Technology in the Clinic and Research Environment.

The British journal of radiology·2026
Same author

A Virtual Clinical Trial to Detect Changes in Tumor Uptake with PET using Lesion Embedding.

IEEE transactions on radiation and plasma medical sciences·2026
Same author

Impact of detector parameters and image resolution modeling on dedicated brain PET imaging.

IEEE transactions on radiation and plasma medical sciences·2026
Same author

Quantitative evaluation of spatially-variant deformations recovered by deep learning on clinical-like breast lesions.

IEEE transactions on radiation and plasma medical sciences·2026

Related Experiment Video

Updated: Jun 17, 2026

Whole-body PET/MRI of Pediatric Patients: The Details That Matter
10:02

Whole-body PET/MRI of Pediatric Patients: The Details That Matter

Published on: December 19, 2017

Improved dose regimen in pediatric PET.

Roberto Accorsi1, Joel S Karp, Suleman Surti

  • 1Department of Radiology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA. raccorsi71@gmail.com

Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|January 19, 2010
PubMed
Summary
This summary is machine-generated.

Pediatric Positron Emission Tomography (PET) can achieve constant image quality with reduced scan times or radiation doses, especially for younger patients. This study provides quantitative rules for optimizing these trade-offs in pediatric PET imaging.

More Related Videos

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
07:57

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform

Published on: March 24, 2022

PET and MRI Guided Irradiation of a Glioblastoma Rat Model Using a Micro-irradiator
10:48

PET and MRI Guided Irradiation of a Glioblastoma Rat Model Using a Micro-irradiator

Published on: December 28, 2017

Related Experiment Videos

Last Updated: Jun 17, 2026

Whole-body PET/MRI of Pediatric Patients: The Details That Matter
10:02

Whole-body PET/MRI of Pediatric Patients: The Details That Matter

Published on: December 19, 2017

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
07:57

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform

Published on: March 24, 2022

PET and MRI Guided Irradiation of a Glioblastoma Rat Model Using a Micro-irradiator
10:48

PET and MRI Guided Irradiation of a Glioblastoma Rat Model Using a Micro-irradiator

Published on: December 28, 2017

Area of Science:

  • Nuclear Medicine
  • Medical Imaging Physics

Background:

  • PET image quality is significantly influenced by patient weight and body mass index.
  • Current adult PET injection protocols use weight-proportional or fixed doses, which may not be optimal for pediatric patients.
  • Optimizing scan time and radiation dose is crucial for pediatric PET to balance image quality and patient burden.

Purpose of the Study:

  • To develop quantitative injection rules for pediatric Positron Emission Tomography (PET).
  • To enable clinical implementation of trade-offs between scan time, radiation dose, and image quality in pediatric patients.
  • To determine patient-specific protocols for optimizing PET imaging in children.

Main Methods:

  • Derived patient-specific noise-equivalent count rate density (NECRD) curves using phantom and clinical data.
  • Estimated retrospective scan time and dose reductions for constant NECRD based on a 70-kg reference adult.
  • Developed predictive models correlating NECRD with injected dose, scan time, and patient weight (n=73).

Main Results:

  • Weight was the strongest correlating patient statistic for developing prospective rules.
  • Formulas were derived to predict time reduction at constant dose (R(2)=0.86) and dose reduction at constant scan time (R(2)=0.88).
  • Significant time or dose savings, up to 50% for the lightest patients (10-20 kg), are possible while maintaining image quality.

Conclusions:

  • Pediatric PET can achieve constant image quality (in an NECRD sense) with optimized scan time and/or dose.
  • The derived quantitative rules allow for substantial reductions in scan time or radiation dose for pediatric patients.
  • These findings support the clinical implementation of tailored PET protocols for children, improving safety and efficiency.